Lymphoblastic Leukemia Clinical Trials

39 clinical trials for Lymphoblastic Leukemia across international registries, including 14 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO) — RECRUITING · PHASE2
• TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II — RECRUITING · PHASE1
• A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL) — RECRUITING · PHASE1
• Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors — RECRUITING · PHASE2
• Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma — RECRUITING · NA
• CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol — RECRUITING · PHASE2
• A PHASE 1/2 OPEN-LABEL STUDY TO INVESTIGATE THE SAFETY, EFFICACY, AND PHARMACOKINETICS OF ADMINISTRATION OF SUBCUTANEOUS BLINATUMOMAB FOR THE TREATMENT OF ADULTS WITH RELAPSED OR REFRACTORY B CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (R/R B ALL — RECRUITING · PHASE1
• CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia — RECRUITING · PHASE1
• A PHASE 3 OPEN-LABEL, RANDOMIZED STUDY OF FIXED DURATION PIRTOBRUTINIB (LOXO-305) PLUS VENETOCLAX AND RITUXIMAB VERSUS VENETOCLAX AND RITUXIMAB IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (BRUIN CLL-322) — RECRUITING · PHASE3
• A PHASE 3 TRIAL INVESTIGATING BLINATUMOMAB (IND #117467, NSC #765986) IN COMBINATION WITH CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED STANDARD RISK OR DOWN SYNDROME B-LYMPHOBLASTIC LEUKEMIA (B-ALL) AND THE TREATMENT OF PATIENTS WITH LOCALIZED B-LYMPHOBLASTIC LYMPHOMA (B-LLY) — RECRUITING · PHASE3
• TOTAL THERAPY FOR INFANTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) — RECRUITING
• LONG TERM FOLLOW-UP OF PATIENTS EXPOSED TO LENTIVIRAL-BASED CD19 DIRECTED CAR T-CELL THERAPY — RECRUITING
• RISK-STRATIFIED RANDOMIZED PHASE III TESTING OF BLINATUMOMAB IN FIRST RELAPSE OF CHILDHOOD B-LYMPHOBLASTIC LEUKEMIA (B-ALL) — RECRUITING · PHASE3
• "A PHASE 2, MULTICENTER, SINGLE-ARM STUDY OF MOXETUMOMAB PASUDOTOX IN PEDIATRIC SUBJECTS WITH RELAPSED OR REFRACTORY PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA (PALL) OR LYMPHOBLASTIC LYMPHOMA OF B-CELL ORIGIN." — RECRUITING · PHASE2
• A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia — NOT_YET_RECRUITING · PHASE1
• Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive and/or BCR::ABL1 Positive Acute Lymphoblastic Leukemia (ALL) — NOT_YET_RECRUITING · PHASE2
• Rapamycin in With High-Dose Etoposide and Cytarabine in Relapsed/Refractory Aggressive Lymphoid Malignancies — TERMINATED · PHASE1
• Study of Brexucabtagene Autoleucel Plus Dasatinib in Adults With Acute Lymphoblastic Leukemia — ACTIVE_NOT_RECRUITING · PHASE1
• A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL) — ACTIVE_NOT_RECRUITING · PHASE1
• Role of Cbc Indices in Acute Lymphoblastic Leukemia Patients — NOT_YET_RECRUITING · NA
• Treatment Protocol for Newky Diagnosed Adult Ph Positive ALL — NOT_YET_RECRUITING
• An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) — COMPLETED · PHASE2
• Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma — COMPLETED · PHASE1
• Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant — COMPLETED · PHASE2
• Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage Leukaemia — OTHER · PHASE1
• Efficacy of Osteopathic Treatment on the Side Effects of Curative Treatments of Lymphoblastic Leukemia in Pediatrics — OTHER
• ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia. — OTHER · PHASE1
• Efficacy and Safety of a Donor Lymphocyte Preparation Depleted of Functional Host Alloreactive T-cells (ATIR) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor — TERMINATED · PHASE2
• Intensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic Malignancies — COMPLETED · NA
• Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma — COMPLETED · PHASE2
• Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL — OTHER · PHASE2
• Nebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute Leukaemia — COMPLETED · PHASE2
• A GROUPWIDE PILOT STUDY TO TEST THE TOLERABILITY AND BIOLOGIC ACTIVITY OF THE ADDITION OF AZACITIDINE (IND# 133688, NSC# 102816) TO CHEMOTHERAPY IN INFANTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) AND KMT2A (MLL) GENE REARRANGEMENT — COMPLETED
• Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus — COMPLETED · PHASE2
• A PHASE II, SINGLE ARM, MULTICENTER TRIAL TO DETERMINE THE EFFICACY AND SAFETY OF CTL019 IN PEDIATRIC PATIENTS WITH RELAPSED OR REFRACTORY B-CELL ACUTE LYMPHOMBLASTIC LEUKEMIA — COMPLETED · PHASE2
• Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors — TERMINATED · NA
• A PHASE II STUDY OF THE ANTI-CD22 RECOMBINANT IMMUNOTOXIN MOXETUMOMAB PASUDOTOX (CAT8015, HA22) IN CHILDREN WITH B-LINEAGE ACTUE LYMPHOBLASTIC LEUKEMIA AND MINIMAL RESIDUAL DISEASE PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION — NOT_YET_RECRUITING · PHASE2
• A PHASE I/II, MULTI-CENTRE, TRIAL OF RUXOLITINIB THERAPY IN COMBINATION WITH NILOTINIB IN PATIENTS WITH PHILADELPHIA POSITIVE CHRONIC MYELOID LEUKEMIA OR ACUTE LYMPHOBLASTIC LEUKEMIA WHO HAVE FAILED TYROSINE KINASE INHIBITOR THERAPY — COMPLETED · PHASE1
• Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma — COMPLETED · PHASE2

Refine this search